Hong Kong’s Regencell Bioscience triples in newest surge for a speculative inventory
Hong Kong Skyline Nikada | E+ | Getty Images Regencell Bioscience Holdings, an early-stage, Hong Kong-based bioscience company with no revenue, is the latest speculative overseas stock to attract an unusual surge in trading demand. Shares of Regencell, which says it develops traditional Chinese herb treatments to treat childhood attention deficit hyperactivity disorder and autism, … Read more
